Exhibit
31.2


CERTIFICATION
PURSUANT TO


18
U.S.C. §1350,


AS
ADOPTED PURSUANT TO


SECTION
302 OF THE SARBANES-OXLEY ACT OF 2002





Certification





I, James
Dorst, Chief Financial Officer and Principal Accounting Officer of
SpectraScience, Inc. certify that:





1.  
I have reviewed this report on Form 10-Q of SpectraScience, Inc.





2.  
Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;





3.  
Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the SpectraScience, Inc. as
of, and for, the periods presented in this report;





4.  
SpectraScience’s other certifying officer and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
SpectraScience, Inc. and have:





(a)
Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to SpectraScience, Inc., including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being
prepared;


(b)
Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;


(c)
Evaluated the effectiveness of SpectraScience’s disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and


(d)
Disclosed in this report any change in SpectraScience’s internal control over
financial reporting that occurred during the Company’s most recent fiscal
quarter that has materially affected, or is reasonably likely to materially
affect, the Company’s internal control over financial reporting;
and





5.  
The Company’s other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the Company’s
auditors and the audit committee of the Company’s board of directors (or persons
performing the equivalent functions):





(a)
  All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect SpectraScience’s ability to record, process,
summarize and report financial information; and


(b)
  Any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer’s internal
control over financial reporting.





November
      16, 2009Signature:
                  /s/
      James DorstName:
                  James
      DorstChief
      Financial
Officer